Targeting a parasite's DNA could be a more effective way to combat malaria, new research from th
READ MORE 2022-07-28Company News | News List
Targeting specific DNA of Plasmodium may be effective in treating human malaria infection
Vijoice is the first FDA-approved PRS treatment
2022.04.06, Novartis announced that the U.S. Food and Drug Administration (FDA) has granted accelera
READ MORE 2022-07-06
Systemic lupus erythematosus (SLE) oral new drug! BMS Novel Oral TYK2 Inhibitor deucravicitinib
Bristol-Myers Squibb (BMS) recently announced positive results from the Phase 2 PAISLEY study (NCT03
READ MORE 2022-06-13
Takeda announced the Phase 3 SHP643 to evaluate the safety and pharmacokinetics of Takhzyro (lanadelumab)
Takeda announced the Phase 3 SHP643 to evaluate the safety and pharmacokinetics of Takhzyro (lanadel
READ MORE 2022-05-13
Bristol-Myers Squibb (BMS) presented 2-year data from the POETYK PSO long-term extension trial of the novel oral TYK2 inhibitor deucravacitinib
Recently, Bristol-Myers Squibb (BMS) presented 2-year data from the POETYK PSO long-term extension t
READ MORE 2022-05-12
ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention
ViiV Healthcare announced that the US Food and Drug Administration (FDA) approvedApretude, the first
READ MORE 2021-12-22
FDA Grants Breakthrough Therapy Designation to Merck’s Novel HIF-2α Inhibitor MK-6482 for Treatment of Certain Patients With Von Hippel-Lindau Disease- Associated Renal Cell Carcinoma
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S.
READ MORE 2021-09-07
Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU
Berlin, Germany, July 21, 2021– The European Commission has granted marketing authorization in the E
READ MORE 2021-07-26
Tagrisso approved in China in early lung cancer
AstraZeneca'sTagrisso(osimertinib) has been approved in China for the adjuvant treatment of pati
READ MORE 2021-04-15
Progress in the development of new and efficient diabetes treatment drugs
Recently, Wang Junfeng's research team from Hefei Institute of Material Science, Chinese Academy
READ MORE 2021-01-19